Inhibition of de novo pyrimidine synthesis augments Gemcitabine induced growth inhibition in an immunocompetent model of pancreatic cancer-Reference-Cited by-同舟云学术

Inhibition of de novo pyrimidine synthesis augments Gemcitabine induced growth inhibition in an immunocompetent model of pancreatic cancer

Published:2021 Issue:9 Volume:17 Page:2240-2251
ISSN:1449-2288
Container-title:International Journal of Biological Sciences
language:en
Short-container-title:Int. J. Biol. Sci.

Author:

Phan Thuy,Nguyen Vu H.,Buettner Ralf,Morales Corey,Yang Lifeng,Wong Paul,Tsai Weiman,Salazar Marcela d'Alincourt,Gil Ziv,Diamond Don J,Rabinowitz Joshua D.,Rosen Steven,Melstrom Laleh G.

Publisher

Ivyspring International Publisher

Subject

Cell Biology,Developmental Biology,Molecular Biology,Applied Microbiology and Biotechnology,Ecology, Evolution, Behavior and Systematics

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recreating metabolic interactions of the tumour microenvironment;Trends in Endocrinology & Metabolism;2024-06

2. Integrative Analyses of Pyrimidine Salvage Pathway-Related Genes Revealing the Associations Between UPP1 and Tumor Microenvironment;Journal of Inflammation Research;2024-01

3. Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma;Journal of Gastrointestinal Oncology;2023-04

4. Prognosis stratification in breast cancer and characterization of immunosuppressive microenvironment through a pyrimidine metabolism-related signature;Frontiers in Immunology;2022-11-29

5. Defects of endoscopic biopsy in the diagnosis of periampullary carcinoma and recommendations for diagnosis and treatment: a retrospective study before and after surgery;Gland Surgery;2022-08